Epilepsi hos eldre

Tidsskrift for den Norske Laegeforening

Volumn 133, Issue 5, 2013, Pages 528-531

  Nakken, Karl O ^a   Sætre, Erik ^a   Markhus, Rune ^a   Lossius, Morten I ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; ETIRACETAM; ISOXAZOLE DERIVATIVE; LAMOTRIGINE; PIRACETAM; TRIAZINE DERIVATIVE; ZONISAMIDE;

AGE; AGED; AGING; ARTICLE; DOSE RESPONSE; EPILEPSY; HUMAN; METABOLISM; QUALITY OF LIFE; SEIZURE;

AGE FACTORS; AGED; AGING; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; HUMANS; ISOXAZOLES; PIRACETAM; QUALITY OF LIFE; SEIZURES; TRIAZINES;

EID: 84875267002     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.12.0781     Document Type: Article

References (54)

1. Rowan AJ, Ramsay RE, Collins JF et al. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64: 1868 - 73.
2. Silveira DC, Jehi L, Chapin J et al. Seizure semiology and aging. Epilepsy Behav 2011; 20: 375 - 7.
3. Banerjee PN, Hauser WA. Incidence and prevalence. I: Engel J jr., Pedley T, red. Epilepsy comprehensive textbook. 2. utg. Philadelphia, PA: Wolters Kluwer, Lippincott Williams & Wilkins, 2008: 45 - 56
4. Svendsen T, Lossius M, Nakken KO. Age-specific prevalence of epilepsy in Oppland County, Norway. Acta Neurol Scand 2007; 116: 307 - 11.
5. Werhahn KJ. Epilepsy in the elderly. Dtsch Arztebl Int 2009; 106: 135 - 42.
6. Verellen RM, Cavazos JE. Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly. Aging Dis 2011; 2: 278 - 85.
7. Faught E, Richman J, Martin R et al. Incidence and prevalence of epilepsy among older U.S. Medicare beneficiaries. Neurology 2012; 78: 448 - 53.
8. Zarrelli MM, Beghi E, Rocca WA et al. Incidence of epileptic syndromes in Rochester, Minnesota: 1980 - 1984. Epilepsia 1999; 40: 1708 - 14.
9. Olafsson E, Ludvigsson P, Gudmundsson G et al. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005; 4: 627 - 34.
10. Rytter E, Nakken KO, Mørch-Reiersen LT et al. Bruk av antiepileptika hos sykehjemsbeboere. Tidsskr Nor Lægeforen 2007; 127: 1185 - 7.
11. Ettinger AB, Shinnar S. New-onset seizures in an elderly hospitalized population. Neurology 1993; 43: 489 - 92.
12. Bladin CF, Alexandrov AV, Bellavance A et al. Seizures after stroke: a prospective multicenter study. Arch Neurol 2000; 57: 1617 - 22.
13. Lossius MI, Rønning OM, Slapø GD et al. Poststroke epilepsy: occurrence and predictors - a long-term prospective controlled study (Akershus Stroke Study). Epilepsia 2005; 46: 1246 - 51.
14. Kammersgaard LP, Olsen TS. Poststroke epilepsy in the Copenhagen stroke study: incidence and predictors. J Stroke Cerebrovasc Dis 2005; 14: 210 - 4.
15. Slapø GD, Lossius MI, Gjerstad L. Poststroke epilepsy: occurrence, predictors and treatment. Expert Rev Neurother 2006; 6: 1801 - 9.
16. Burn J, Dennis M, Bamford J et al. Epileptic seizures after a first stroke: the Oxfordshire Community Stroke Project. BMJ 1997; 315: 1582 - 7.
17. Menon B, Shorvon SD. Ischaemic stroke in adults and epilepsy. Epilepsy Res 2009; 87: 1 - 11.
18. Lossius MI, Rønning OM, Mowinckel P et al. Incidence and predictors for post-stroke epilepsy. A prospective controlled trial. The Akershus stroke study. Eur J Neurol 2002; 9: 365 - 8.
19. Fjærtoft H, Indredavik B. Kostnadsvurderinger ved hjerneslag. Tidsskr Nor Lægeforen 2007; 127: 744 - 7.
20. Cleary P, Shorvon S, Tallis R. Late-onset seizures as a predictor of subsequent stroke. Lancet 2004; 363: 1184 - 6.
21. Beghi E, Carpio A, Forsgren L et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia 2010; 51: 671 - 5.
22. Camilo O, Goldstein LB. Seizures and epilepsy after ischemic stroke. Stroke 2004; 35: 1769 - 75.
23. Scarmeas N, Honig LS, Choi H et al. Seizures in Alzheimer disease: who, when, and how common? Arch Neurol 2009; 66: 992 - 7.
24. Maschio M, Dinapoli L. Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumorrelated epilepsy. Neurol Sci 2011; 32 (suppl 2): S259 - 62.
25. Rowan AJ. Seizure. Fundamentals of drug management of epilepsy in the older patient. Geriatrics 2002; 57: 33 - 7.
26. Cloyd J, Hauser WA, Towne A et al. Epidemiological and medical aspects of epilepsy in the elderly. Epilepsy Res 2006; 68 (suppl 1): S39 - 48.
27. Ramsay RE, Rowan AJ, Pryor FM. Special considerations in treating the elderly patient with epilepsy. Neurology 2004; 62 (suppl 2): S24 - 9.
28. Sheth RD, Drazkowski JF, Sirven JI et al. Protracted ictal confusion in elderly patients. Arch Neurol 2006; 63: 529 - 32.
29. Ramsay RE, Pryor F. Epilepsy in the elderly. Neurology 2000; 55 (suppl 1): S9 - 14.
30. DeLorenzo RJ, Hauser WA, Towne AR et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996; 46: 1029 - 35.
31. Walker MC. Diagnosis and treatment of nonconvulsive status epilepticus. CNS Drugs 2001; 15: 931 - 9.
32. Spitz MC, Bainbridge JL, Winzenburg KV et al. Observation on the delay in diagosis of seizures in the elderly: update 3. Epilepsia 2003; 44 (suppl 9): 18.
33. Brodie MJ, Elder AT, Kwan P. Epilepsy in later life. Lancet Neurol 2009; 8: 1019 - 30.
34. Drury I, Selwa LM, Schuh LA et al. Value of inpatient diagnostic CCTV-EEG monitoring in the elderly. Epilepsia 1999; 40: 1100 - 2.
35. Van Cott AC. Epilepsy and EEG in the elderly. Epilepsia 2002; 43 (suppl 3): 94 - 102.
36. Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly. Neurology 2004; 63 (suppl 4): S40 - 8.
37. Leppik IE, Birnbaum AK. Epilepsy in the elderly. Ann N Y Acad Sci 2010; 1184: 208 - 24.
38. Feely J, Coakley D. Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990; 6: 269 - 83.
39. Read CL, Stephen LJ, Stolarek IH et al. Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study. Seizure 1998; 7: 159 - 62.
40. Perucca E, Berlowitz D, Birnbaum A et al. Pharmacological and clinical aspects of antiepileptic drug use in the elderly. Epilepsy Res 2006; 68 (suppl 1): S49 - 63.
41. Tomson T, Kennebäck G. Arrythmia, heart rate variability, and antiepileptic drugs. Epilepsia 1997; 38 (suppl 11): S48 - 51.
42. Mintzer S, Boppana P, Toguri J et al. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 2006; 47: 510 - 5.
43. Chuang Y-C, Chuang H-Y, Lin T-K et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia 2012; 53: 120 - 8.
44. Galimberti CA, Magri F, Magnani B et al. Antiepileptic drug use and epileptic seizures in elderly nursing home residents: a survey in the province of Pavia, Northern Italy. Epilepsy Res 2006; 68: 1 - 8.
45. Mattson RH, Cramer JA, Collins JF et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313: 145 - 51.
46. Stephen LJ, Kelly K, Mohanraj R et al. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav 2006; 8: 434 - 7.
47. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999; 37: 81 - 7.
48. Saetre E, Perucca E, Isojärvi J et al. An international multicenter randomized double-blind controlled trial of lamotrigine and sustainedrelease carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007; 48: 1292 - 302.
49. Marson AG, Appleton R, Baker GA et al. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess 2007; 11: iii-iv, ix-x, 1 - 134.
50. Arif H, Buchsbaum R, Pierro J et al. Comparative effectiveness of 10 antiepileptic drugs in older adults with epilepsy. Arch Neurol 2010; 67: 408 - 15.
51. Sirven JI, Malamut BL, O'Connor MJ et al. Temporal lobectomy outcome in older versus younger adults. Neurology 2000; 54: 2166 - 70.
52. Grivas A, Schramm J, Kral T et al. Surgical treatment for refractory temporal lobe epilepsy in the elderly: seizure outcome and neuropsychological sequels compared with a younger cohort. Epilepsia 2006; 47: 1364 - 72.
53. Sirven JI, Sperling M, Naritoku D et al. Vagus nerve stimulation therapy for epilepsy in older adults. Neurology 2000; 54: 1179 - 82.
54. Kennedy SH, Giacobbe P. Treatment resistant depression-advances in somatic therapies. Ann Clin Psychiatry 2007; 19: 279 - 87.